Pemetrexed 100 MG Injection [Alimta] — RxCUI 1728079
RxNorm drug concept · Semantic branded drug
RxCUI 1728079
Semantic branded drug · SBD
● Current RxNorm concept 2 FDA products
2 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1728079
Official namePemetrexed 100 MG Injection [Alimta]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asAlimta 100 MG Injection
FDA products mapped2
Package NDCs mapped2
Reported Medicaid activity (SDUD)936 prescriptions · 12 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Pemetrexed Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Yes, they are absolutely necessary and not optional. The folic acid and vitamin B12 help protect your bone marrow and gut lining from the most severe side effects of pemetrexed — c...
- Why do I have to take vitamins and a steroid along with my chemo — are they really necessary?
- You need to be careful with ibuprofen. It can block one of the kidney transporters that your body uses to clear pemetrexed, which means pemetrexed can build up to higher levels and...
- Can I take ibuprofen or Advil while I'm on this treatment?
🕸️ Concept Web — How Pemetrexed 100 MG Injection [Alimta] Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Pemetrexed 100 MG Injection [Alimta]
RxCUI 1728079 Semantic branded drug · SBD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Pemetrexed
68446IN
-
Pemetrexed
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Alimta
323879BN
-
Alimta
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Pemetrexed Injection
1728071SCDF -
Pemetrexed Injectable Product
1161384SCDG -
Pemetrexed Injection [Alimta]
1728074SBDF -
Alimta Injectable Product
1175526SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Pemetrexed Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Pemetrexed 100 MG Injection
1728077SCD -
Pemetrexed 100 MG
1728076SCDC -
Pemetrexed 100 MG [Alimta]
1728078SBDC
-
Pemetrexed 100 MG Injection
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Pemetrexed 100 MG Injection
SCD · 1728077 -
Pemetrexed 100 MG
SCDC · 1728076 -
Pemetrexed Injection
SCDF · 1728071 -
Pemetrexed Injectable Product
SCDG · 1161384
Brand-Name Concepts
-
Pemetrexed 100 MG [Alimta]
SBDC · 1728078 -
Pemetrexed Injection [Alimta]
SBDF · 1728074 -
Alimta Injectable Product
SBDG · 1175526 -
Alimta
BN · 323879
📦 FDA Products & Package NDCs
2 products · 2 package NDCs
2 package NDCs map to RxCUI 1728079 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00002-7623-01 | 1 VIAL in 1 CARTON (0002-7623-01) / 20 mL in 1 VIAL | Alimta | Eli Lilly and Company | 2004-02-13 |
| 00002-7640-01 | 1 VIAL in 1 CARTON (0002-7640-01) / 4 mL in 1 VIAL | Alimta | Eli Lilly and Company | 2008-01-15 |
Observed labelers:
Eli Lilly and Company (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J9305 | Inj. pemetrexed nos 10mg | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.